These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 19352271)

  • 1. Imaging of a paraganglioma on C-11 choline PET/CT.
    Rahbar K; Fuchs M; Kemper S; Juergens KU; Weckesser M; Stegger L
    Clin Nucl Med; 2009 Feb; 34(2):119-21. PubMed ID: 19352271
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of trigger PSA and PSA kinetics on (11)C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy.
    Jadvar H
    J Nucl Med; 2010 Mar; 51(3):498-9; author reply 499-500. PubMed ID: 20150273
    [No Abstract]   [Full Text] [Related]  

  • 3. Could choline PET play a role in malignancies other than prostate cancer?
    Nanni C; Rubello D; Fanti S
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):216-8. PubMed ID: 17899074
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidental detection of Leydig cell tumor via fluorine-18-Choline PET/CT in a patient with recurrent prostate cancer disease.
    Cimitan M; Hodolič M; Maffione AM; Borsatti E; Urso C; Colletti PM; Rubello D
    Clin Nucl Med; 2013 Sep; 38(9):752-4. PubMed ID: 23856823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidental detection of Hürthle cell adenoma by 18F-choline PET/CT scan in a patient with prostate cancer.
    Paone G; Treglia G; Bongiovanni M; Ruberto T; Ceriani L; Giovanella L
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):340-1. PubMed ID: 23796426
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of PET/CT and current challenges in prostate cancer management.
    Lindholm P; Seppänen M; Minn H
    Nucl Med Commun; 2009 May; 30(5):325. PubMed ID: 19421025
    [No Abstract]   [Full Text] [Related]  

  • 7. [PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer].
    García JR; Soler M; Blanch MA; Ramírez I; Riera E; Lozano P; Pérez X; Delgado E; Carrio I; Lomeña F
    Rev Esp Med Nucl; 2009; 28(3):95-100. PubMed ID: 19558948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biochemical recurrence after curative treatment for localized prostate cancer: Performance of choline PET/CT in the assessment of local recurrence].
    Brenot-Rossi I
    Prog Urol; 2015 Oct; 25(12):716-7. PubMed ID: 26184041
    [No Abstract]   [Full Text] [Related]  

  • 9. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    Schiavina R; Scattoni V; Castellucci P; Picchio M; Corti B; Briganti A; Franceschelli A; Sanguedolce F; Bertaccini A; Farsad M; Giovacchini G; Fanti S; Grigioni WF; Fazio F; Montorsi F; Rigatti P; Martorana G
    Eur Urol; 2008 Aug; 54(2):392-401. PubMed ID: 18456393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-specific antigen and radiolabelled choline PET/CT for the assessment of response to therapy: synergy or conflicting?
    Evangelista L; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):200-201. PubMed ID: 26493310
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion.
    Ambrosini V; Farsad M; Nanni C; Schiavina R; Rubello D; Castellucci P; Pasquini E; Franchi R; Cavo M; Fanti S
    Eur J Nucl Med Mol Imaging; 2006 Dec; 33(12):1522. PubMed ID: 16896665
    [No Abstract]   [Full Text] [Related]  

  • 12. The rising PET: the increasing use of choline PET/CT in prostate cancer.
    Chiti A; Picchio M
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):53-4. PubMed ID: 21103870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metabolic and osteogenic pattern of prostate cancer bone metastases].
    García JR; Riera E; Valls E; Soler M; Moragas M; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):33-6. PubMed ID: 22835661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
    García Vicente AM; Núñez García A; Soriano Castrejón AM; Jiménez Londoño GA; Cordero García JM; Palomar Muñoz A
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):37-9. PubMed ID: 23177342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.
    Budiharto T; Joniau S; Lerut E; Van den Bergh L; Mottaghy F; Deroose CM; Oyen R; Ameye F; Bogaerts K; Haustermans K; Van Poppel H
    Eur Urol; 2011 Jul; 60(1):125-30. PubMed ID: 21292388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
    Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
    Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pro and contra: 11C choline PET in diagnosis of prostate cancer].
    Kotzerke J; Zöphel K; Salomon G; Graefen M; Heidenreich A
    Aktuelle Urol; 2007 May; 38(3):189-94. PubMed ID: 17566231
    [No Abstract]   [Full Text] [Related]  

  • 18. 11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.
    Rinnab L; Blumstein NM; Mottaghy FM; Hautmann RE; Küfer R; Hohl K; Reske SN
    BJU Int; 2007 Jun; 99(6):1421-6. PubMed ID: 17355373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
    Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
    Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.
    DeGrado TR; Coleman RE; Wang S; Baldwin SW; Orr MD; Robertson CN; Polascik TJ; Price DT
    Cancer Res; 2001 Jan; 61(1):110-7. PubMed ID: 11196147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.